CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Investigational LINQ™ HF RAMwaredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03608826
NCT03608826N/ACompleted
CompareCT.gov

Relationship Between LINQ™ Subcutaneous Impedance and Right-sided Hemodynamic Measurements

Medtronic Cardiac Rhythm and Heart Failure·interventional·Posted Aug 1, 2018·Updated Dec 23, 2022

In Brief

A clinical study evaluating Investigational LINQ™ HF RAMware for Heart Failure. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The purpose of the ReLINQuish study is to characterize the relationship between subcutaneous impedance and hemodynamic measurements in patients with heart failure. Additionally, the relationship between changes in subcutaneous impedance and other physiologic parameters during acute decompensated HF events will be characterized.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 1, 2018
Enrollment StartJul 13, 2018
Primary CompletionMay 7, 2021
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 7.9 years ago

Interventions

Investigational LINQ™ HF RAMwaredevice

The Reveal LINQ™ device and the 2090 programmer are market-released, but once the investigational LINQ™ HF RAMware is downloaded into the devices, they are considered investigational.